« Back to Record
Citation APA

Desmedt, C., de Azambuja, E., Di Leo, A., Larsimont, D., Durbecq, V., Antoine, D., Lallemand, F., Haibe-Kains, B., Cardoso, F., Nogaret, J.-M., Fontaine, D., Liebens, F., Duhem, C., Kains, J.-P., Maerevoet, M., Richard, V., Vindevoghel, A., Delaloge, S., Buyse, M., D'Hondt, V., Piccart-Gebhart, M., & Sotiriou, C. (2006). Gene expression profiling can predict pathological complete response (pCR) to anthracycline-monotherapy in estrogen-receptor (ER) negative breast cancer (BC) patients. Poster session presented at San Antonio Breast Cancer Symposium (29th: December 2006: San Antonio, Tx, USA).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/153694

Desmedt, C., de Azambuja, E., Di Leo, A., Larsimont, D., Durbecq, V., Antoine, D., Lallemand, F., Haibe-Kains, B., Cardoso, F., Nogaret, J.-M., Fontaine, D., Liebens, F., Duhem, C., Kains, J.-P., Maerevoet, M., Richard, V., Vindevoghel, A., Delaloge, S., Buyse, M., D'Hondt, V., Piccart-Gebhart, M., & Sotiriou, C. (2006). Gene expression profiling can predict pathological complete response (pCR) to anthracycline-monotherapy in estrogen-receptor (ER) negative breast cancer (BC) patients. Poster session presented at San Antonio Breast Cancer Symposium (29th: December 2006: San Antonio, Tx, USA).